United Therapeutics Corporation (UTHR)
Add to Watchlists Create an Alert
66.35
-1.26 -1.86%
NASDAQ
May 24, 5:00PM
BATS Real time
Currency in USD
United Therapeutics Corporation Interest Expense:
4.436M for March 31, 2013United Therapeutics Corporation Historical Interest Expense Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 4.436M |
| Dec. 31, 2012 | 4.49M |
| Sept. 30, 2012 | 4.384M |
| June 30, 2012 | 3.879M |
| March 31, 2012 | 3.886M |
| Dec. 31, 2011 | 5.111M |
| Sept. 30, 2011 | 5.416M |
| June 30, 2011 | 5.431M |
| March 31, 2011 | 5.41M |
| Dec. 31, 2010 | 5.455M |
| Sept. 30, 2010 | 4.809M |
| June 30, 2010 | 4.759M |
| March 31, 2010 | 4.687M |
| Dec. 31, 2009 | 3.659M |
| Sept. 30, 2009 | 3.331M |
| June 30, 2009 | 3.248M |
| March 31, 2009 | 2.637M |
| Dec. 31, 2008 | 2.53M |
| Sept. 30, 2008 | 2.624M |
| June 30, 2008 | 0.00 |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Interest Expense
When companies borrow money to expand or maintain their business operations, they must pay interest on the money that they borrow. The interest expense is the annual accrued amount of interest that the company paid (or sometimes will have to pay) to its creditors.
A higher interest expense means that the company is paying more to its debtors. In general, a company's capital structure with a heavier debt focus will have higher interest expenses. Liquidity ratios such as EBIT/Interest Expense can help investors see if increasing Interest Expenses are problematic.
YCharts includes both operating interest expense and non-operating interest expense in our numbers.
Learn More
UTHR Interest Expense Benchmarks
| Companies | |
|---|---|
| Pluristem Therapeutic | 0.00 |
| Celgene Corporation | 17.90M |
| Lannett Company | 0.072M |
UTHR Interest Expense Rankings
| Overall |
48th percentile 4162 of 8009 |
| Sector |
20th percentile 544 of 687 in Healthcare |
| Industry |
15th percentile 210 of 248 in Biotechnology |
UTHR Interest Expense Range, Past 5 Years
| Minimum | 0.00 | Jun 2008 |
| Maximum | 5.455M | Dec 2010 |
| Average | 4.009M |
